Latest Articles
- The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults
Patients can have variable responses to vaccines, depending on the vaccine and the DMARD.
- Does my healthy 65-year-old patient still need the 13-valent pneumococcal conjugate vaccine (PCV13)?
The short answer is no—but it is not that simple.
- Double the reasons for giving the flu vaccine in 2020
Limiting the impact of other diseases, possibly including COVID-19.
- Convalescent plasma for COVID-19: Promising, not proven
The evidence is suggestive but weak. Trials are ongoing.
- Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?
Triple therapy is aggressive and carries high risks of bleeding and death.
- Verrucous plaques on the face, dysphagia, and limb weakness
An itchy bump on the upper lip rapidly grew and spread.
- Overcoming obesity: Weight-loss drugs are underused
Successful management of obesity requires a multifaceted approach.
- 5-Fluorouracil–induced encephalopathy
A woman on chemotherapy for rectal cancer presents with mental status changes.